Back to top

Halozyme price target raised to $95 from $75 at Wells Fargo

Wells Fargo raised the firm’s price target on Halozyme (HALO) to $95 from $75 and keeps an Equal Weight rating on the shares. The firm cites a Q2 b...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Halozyme Therapeutics, Inc. (HALO)